Stucchi Mattia, Gmeiner Peter, Huebner Harald, Rainoldi Giulia, Sacchetti Alessandro, Silvani Alessandra, Lesma Giordano
Dipartimento di Chimica, Universit degli Studi di Milano , via Golgi 19, 20133 Milano, Italy.
Department of Chemistry and Pharmacy Emil Fischer Center, Friedrich Alexander University , Schuhstraße 19, D-91052 Erlangen, Germany.
ACS Med Chem Lett. 2015 Jun 23;6(8):882-7. doi: 10.1021/acsmedchemlett.5b00131. eCollection 2015 Aug 13.
A series of 1,4-disubstituted piperazine-based compounds were designed, synthesized, and evaluated as dopamine D2/D3 receptor ligands. The synthesis relies on the key multicomponent split-Ugi reaction, assessing its great potential in generating chemical diversity around the piperazine core. With the aim of evaluating the effect of such diversity on the dopamine receptor affinity, a small library of compounds was prepared, applying post-Ugi transformations. Ligand stimulated binding assays indicated that some compounds show a significant affinity, with K i values up to 53 nM for the D2 receptor. Molecular docking studies with the D2 and D3 receptor homology models were also performed on selected compounds. They highlighted key interactions at the indole head and at the piperazine moiety, which resulted in good agreement with the known pharmacophore models, thus helping to explain the observed structure-activity relationship data. Molecular insights from this study could enable a rational improvement of the split-Ugi primary scaffold, toward more selective ligands.
设计、合成并评估了一系列基于1,4 - 二取代哌嗪的化合物作为多巴胺D2/D3受体配体。合成过程依赖关键的多组分拆分 - Ugi反应,评估其在哌嗪核心周围产生化学多样性方面的巨大潜力。为了评估这种多样性对多巴胺受体亲和力的影响,通过Ugi反应后转化制备了一个小型化合物库。配体刺激结合试验表明,一些化合物表现出显著的亲和力,D2受体的Ki值高达53 nM。还对选定的化合物进行了与D2和D3受体同源模型的分子对接研究。这些研究突出了吲哚头部和哌嗪部分的关键相互作用,这与已知的药效团模型高度一致,从而有助于解释观察到的构效关系数据。这项研究的分子见解能够合理改进拆分 - Ugi初级支架,以获得更具选择性的配体。